Rescue of extreme hepatectomy mice by primary hepatocyte-derived 3D bio-printed organ transplantation
Source abstract
Abstract
Abstract Three-dimensional (3D) bioprinting is an emerging strategy for constructing tissues and organs in vitro . Here, we achieved long-term expansion of primary mouse hepatocytes using a defined medium and constructed liver tissue using 3D bioprinting. The 3D-printed liver tissue demonstrated several essential liver functions and was able to prolong the survival of mice with acute liver failure due to extreme hepatectomy after in vivo transplantation, and the transplanted artificial liver tissue showed distinct functional partitioning. Overall, our results develop a method for long-term in vitro culture of primary hepatocytes and demonstrate the potential of 3D bio-printed liver tissue for clinical translational applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Liver physiology and pathology · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Liver regeneration: biological and pathological mechanisms and implications10.1038/s41575-020-0342-4 ↗
2. The origin of newborn hepatocytes in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)-derived regeneration10.21037/hbsn.2020.03.13 ↗
3. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation10.1016/j.jhep.2021.01.007 ↗
4. Challenges to liver transplantation and strategies to improve outcomes10.1053/j.gastro.2014.08.045 ↗
5. Cell therapy for advanced liver diseases: repair or rebuild10.1016/j.jhep.2020.09.014 ↗
6. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure10.1186/1741-7015-10-56 ↗
7. Liver tissue engineering: from implantable tissue to whole organ engineering10.1002/hep4.1136 ↗
8. Current progress in hepatic tissue regeneration by tissue engineering10.1186/s12967-019-02137-6 ↗
9. Bioprinting for the biologist10.1016/j.cell.2020.12.002 ↗
10. Three-dimensional bioprinted liver tissue for transplantation: hope or hype?10.21037/hbsn-20-549 ↗
11. 3D printing of personalized thick and perfusable cardiac patches and hearts10.1002/advs.201900344 ↗
12. Multivascular networks and functional intravascular topologies within biocompatible hydrogels10.1126/science.aav9750 ↗
13. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure10.1136/gutjnl-2019-319960 ↗
14. In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity10.1016/j.stem.2018.10.018 ↗
15. Long-term functional maintenance of primary human hepatocytes in vitro10.1126/science.aau7307 ↗
16. Inflammatory cytokine TNFalpha promotes the long-term expansion of primary hepatocytes in 3D culture10.1016/j.cell.2018.11.012 ↗
17. Long-term expansion of functional mouse and human hepatocytes as 3D organoids10.1016/j.cell.2018.11.013 ↗
18. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity10.1016/j.stem.2016.10.007 ↗
19. Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion10.1038/cr.2017.47 ↗
20. In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules10.1016/j.scr.2021.102523 ↗
21. Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes10.1126/sciadv.ado1550 ↗
22. Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing10.1088/1758-5090/aba0c3 ↗
23. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model10.1073/pnas.0710528105 ↗
24. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation10.1073/pnas.88.4.1217 ↗
25. Role of platelets on liver regeneration after 90% hepatectomy in mice10.1016/j.jhep.2008.04.019 ↗
26. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine10.1016/j.biomaterials.2020.120416 ↗
27. Application of a 3D bioprinted hepatocellular carcinoma cell model in antitumor drug research10.3389/fonc.2020.00878 ↗
28. The bioprinting roadmap10.1088/1758-5090/ab5158 ↗
29. Developments and opportunities for 3D bioprinted organoids10.18063/ijb.v7i3.364 ↗
30. Current advances on 3D-bioprinted liver tissue models10.1002/adhm.202001517 ↗
31. Global liver disease burdens and research trends: analysis from a Chinese perspective10.1016/j.jhep.2019.03.004 ↗
32. The global burden of liver disease: a challenge for methods and for public health10.1186/s12916-014-0159-5 ↗
33. Artificial intelligence is poised to revolutionize human liver allocation and decrease medical costs associated with liver transplantation10.21037/hbsn-20-458 ↗
34. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice10.1053/j.gastro.2012.08.024 ↗
35. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes10.1053/j.gastro.2008.10.047 ↗
36. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development10.1002/hep.23506 ↗
37. Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction10.1016/j.jhep.2012.04.038 ↗
38. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors10.1038/nature10116 ↗
39. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes10.1016/j.stem.2014.01.003 ↗
40. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells10.1053/j.gastro.2008.03.015 ↗
41. Long-term culture and expansion of primary human hepatocytes10.1038/nbt.3377 ↗
42. Clinical application of hepatocyte transplantation: current status, applicability, limitations, and future outlook10.1080/17474124.2020.1733975 ↗
43. The efficacy of the hepatocyte spheroids for hepatocyte transplantation10.1177/09636897211000014 ↗
44. Liver zonation, revisited10.1002/hep.32408 ↗
45. The role of liver zonation in physiology, regeneration, and disease10.1055/s-0041-1742279 ↗